HCA Healthcare (NYSE:HCA) Stock Price Expected to Rise, Mizuho Analyst Says

HCA Healthcare (NYSE:HCA) had its price objective lifted by research analysts at Mizuho from $505.00 to $520.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Mizuho’s target price would suggest a potential upside of 10.27% from the company’s previous close.

Other equities research analysts have also issued research reports about the stock. Bank of America upped their price objective on shares of HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a report on Monday, October 27th. Wall Street Zen upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Oppenheimer lifted their price target on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. Finally, UBS Group lifted their target price on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $476.74.

HCA Healthcare Trading Up 0.4%

HCA stock opened at $471.55 on Thursday. The firm has a 50-day moving average of $468.00 and a two-hundred day moving average of $415.82. The company has a market cap of $107.60 billion, a price-to-earnings ratio of 18.23, a PEG ratio of 1.39 and a beta of 1.36. HCA Healthcare has a 12 month low of $289.98 and a 12 month high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts forecast that HCA Healthcare will post 24.98 earnings per share for the current year.

Insider Activity at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. Mirabella Financial Services LLP raised its position in shares of HCA Healthcare by 112.2% during the 3rd quarter. Mirabella Financial Services LLP now owns 12,715 shares of the company’s stock worth $5,408,000 after acquiring an additional 6,724 shares in the last quarter. Hudson Bay Capital Management LP lifted its position in shares of HCA Healthcare by 154.5% during the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after buying an additional 2,849 shares during the last quarter. Allworth Financial LP raised its stake in HCA Healthcare by 20.8% during the 3rd quarter. Allworth Financial LP now owns 1,174 shares of the company’s stock worth $500,000 after acquiring an additional 202 shares in the last quarter. IFP Advisors Inc grew its holdings in shares of HCA Healthcare by 5.5% during the third quarter. IFP Advisors Inc now owns 8,277 shares of the company’s stock worth $3,528,000 after purchasing an additional 434 shares during the last quarter. Finally, Cambria Investment Management L.P. acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $273,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.